Chemistry:Tibulizumab

From HandWiki
Tibulizumab
Monoclonal antibody
Type?
SourceHumanized
TargetBAFF
Clinical data
Other namesLY 3090106
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC8934H13698N2398O2808S56
Molar mass201.4 g/mol g·mol−1

Tibulizumab (LY 3090106) (INN[1]) is a humanized monoclonal antibody designed for the treatment of autoimmune diseases.

This drug was developed by Eli Lilly and Co.[2]

References